World Lifestyler
  • Art & Culture
    • Books & Literature
    • Cinema & Film
    • Design & Architecture
    • Exhibitions
    • Theatre
    • Music
  • Lifestyle
    • Fashion
    • Health & Fitness
    • Home & Living
    • Luxury Living
    • Car Reviews
    • Collectors
    • Luxury Cars
    • Planes
    • Private Jets
    • Yachts
  • Travel
    • Exclusives
    • Fashion Events
    • Festivals
    • Meetups
    • Outdoor Excursions
    • Road Trips
    • VIP Experiences
  • Food & Drink
    • Beers & Spirits
    • Chefs & Cooks
    • City Eating Guides
    • Fine Dining
    • Recipes
    • Restaurant Reviews
  • Adventure & Tours
  • City Guides
  • Cruises
  • Resorts & Spas
  • Reviews & Tips
  • Art & Culture
    • Books & Literature
    • Cinema & Film
    • Design & Architecture
    • Exhibitions
    • Theatre
    • Music
  • Lifestyle
    • Fashion
    • Health & Fitness
    • Home & Living
    • Luxury Living
    • Car Reviews
    • Collectors
    • Luxury Cars
    • Planes
    • Private Jets
    • Yachts
  • Travel
    • Exclusives
    • Fashion Events
    • Festivals
    • Meetups
    • Outdoor Excursions
    • Road Trips
    • VIP Experiences
  • Food & Drink
    • Beers & Spirits
    • Chefs & Cooks
    • City Eating Guides
    • Fine Dining
    • Recipes
    • Restaurant Reviews
  • Adventure & Tours
  • City Guides
  • Cruises
  • Resorts & Spas
  • Reviews & Tips
No Result
View All Result
World Lifestyler
No Result
View All Result
Home Lifestyle Health & Fitness

Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026

Cision PR Newswire by Cision PR Newswire
February 23, 2026
in Health & Fitness
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

WARSAW, Ind., Feb. 23, 2026 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2026. The cash dividend of $0.24 per share is payable on or about April 30, 2026 to stockholders of record as of the close of business on March 31, 2026.


(PRNewsfoto/Zimmer Biomet Holdings, Inc.)

About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. 

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X at www.x.com/zimmerbiomet.

Contacts:

Media  

Investors

Troy Kirkpatrick

David DeMartino

614-284-1926

646-531-6115

troy.kirkpatrick@zimmerbiomet.com

david.demartino@zimmerbiomet.com

Kirsten Fallon

Zach Weiner

781-779-5561

908-591-6955

kirsten.fallon@zimmerbiomet.com

zach.weiner@zimmerbiomet.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-announces-quarterly-dividend-for-first-quarter-of-2026-302693720.html

SOURCE Zimmer Biomet Holdings, Inc.

Cision PR Newswire

Cision PR Newswire

Related Posts

Residential Home Health Expands Eastern Pennsylvania Footprint with Acquisition of Covenant Home Health

March 9, 2026

In HelloNation, Cannabis Expert Shellie Grammer of Roseburg Clarifies THC vs. CBD Effects

March 9, 2026

MWW Health Launches HealthPulse, an AI-Powered Policy Intelligence and Communications Solution for Healthcare Leaders

March 9, 2026

bitBiome and Kyoritsu Seiyaku Announce Strategic Collaboration in Animal Health and Nutrition

March 9, 2026

PrimeC Long-Term Survival Data to Be Presented at a Leading ALS Scientific Conference

March 9, 2026

Brogidirsen (NS-089/NCNP-02) 4.5-Year Clinical Trial Data for the Treatment of Duchenne Muscular Dystrophy Presented at 2026 MDA Clinical & Scientific Conference

March 9, 2026

Popular News

  • Leeds Bradford Airport chooses A-SAFE for new terminal and baggage safety systems

    0 shares
    Share 0 Tweet 0
  • Huawei and China Telecom Win GSMA GLOMO for Enhancing the Lives of Children and Young People

    0 shares
    Share 0 Tweet 0
  • “At Three in the Afternoon”: A Poetic Dialogue Beyond Borders

    0 shares
    Share 0 Tweet 0
  • Beelink Launches OpenClaw Pre-installed Series: Exclusive Lobster Red Editions and SSD Upgrade Kits for a Seamless AI Experience

    0 shares
    Share 0 Tweet 0
  • Direct Selling Takes Center Stage at 18th World Federation of Direct Selling Associations World Congress in Incheon, Korea

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler